Cytotherapy

0.7(top 50%)

impact factor

6.1K(top 5%)

papers

88.7K(top 5%)

citations

104(top 5%)

h-index

0.7(top 50%)

impact factor

7.8K

all documents

94.0K

doc citations

211(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement	Cytotherapy	2006	13,839
2	Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement	Cytotherapy	2005	1,661
3	Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)	Cytotherapy	2013	1,469
4	Adipose-derived adult stem cells: isolation, characterization, and differentiation potential	Cytotherapy	2003	964
5	Yield of human adipose-derived adult stem cells from liposuction aspirates	Cytotherapy	2004	612
6	Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature	Cytotherapy	2019	466
7	Immunomodulatory effects of fetal and adult mesenchymal stem cells	Cytotherapy	2003	455
8	International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials	Cytotherapy	2016	400
9	Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure	Cytotherapy	2006	389
10	Treatment of patients with advanced cancer with the natural killer cell line NK-92	Cytotherapy	2013	386
11	A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer	Cytotherapy	2011	374
12	The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?	Cytotherapy	2013	369
13	Immunological characterization of multipotent mesenchymal stromal cells—The International Society for Cellular Therapy (ISCT) working proposal	Cytotherapy	2013	364
14	Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial	Cytotherapy	2008	347
15	The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration	Cytotherapy	2016	346
16	Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration	Cytotherapy	2009	330
17	Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpoints	Cytotherapy	2013	312
18	Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing	Cytotherapy	2012	300
19	Defining the risks of mesenchymal stromal cell therapy	Cytotherapy	2010	279
20	Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta	Cytotherapy	2004	257
21	Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells	Cytotherapy	2009	257
22	Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia	Cytotherapy	2014	253
23	Mesenchymal stem cells: progress toward promise	Cytotherapy	2005	249
24	Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy	Cytotherapy	2011	246
25	Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components	Cytotherapy	2012	246
26	Heterogeneity of mesenchymal stromal cell preparations	Cytotherapy	2008	239
27	Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture	Cytotherapy	2005	238
28	Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells	Cytotherapy	1999	229
29	Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM	Cytotherapy	2006	221
30	Mesenchymal stem cells: progress toward promise	Cytotherapy	2005	219
31	Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells	Cytotherapy	2014	216
32	Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells	Cytotherapy	2016	210
33	Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study	Cytotherapy	2009	208
34	Mesenchymal stem/progenitor cells developed in cultures from UC blood	Cytotherapy	2004	204
35	Exosomes from dental pulp stem cells rescue human dopaminergic neurons from 6-hydroxy-dopamine–induced apoptosis	Cytotherapy	2015	196
36	Mesenchymal stromal cells: tissue repair and immune modulation	Cytotherapy	2006	195
37	MSC-exosome: A novel cell-free therapy for cutaneous regeneration	Cytotherapy	2018	191
38	Is CD34 truly a negative marker for mesenchymal stromal cells?	Cytotherapy	2012	186
39	Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro	Cytotherapy	2009	185
40	Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model	Cytotherapy	2009	184
41	Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study	Cytotherapy	2012	181
42	Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells	Cytotherapy	2001	179
43	Characterization of adipose tissue-derived cells isolated with the Celution™ system	Cytotherapy	2008	179
44	Treatment of stress urinary incontinence with adipose tissue-derived stem cells	Cytotherapy	2010	174
45	Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS Prodigy	Cytotherapy	2016	174
46	Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6	Cytotherapy	2009	169
47	Mesenchymal stromal cells alone or expressing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment	Cytotherapy	2010	166
48	Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage	Cytotherapy	2008	165
49	Mesenchymal stem cells in hematopoietic stem cell transplantation	Cytotherapy	2009	163
50	Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications	Cytotherapy	2012	163

Scientometrics

Overviews

Citing Bodies

Cytotherapy

Top Articles